Lucy Horton is an Infectious Disease physician affiliated with Pfizer. OpenAlex indexes 33 publications with 854 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1000 10th Ave
Dept. Of Medicine 3a-C2
New York, NY 100191147
Telephone
650-468-5998Registry record last updated 1 Aug 2019.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year20224 payments
- Astellas Pharma US IncProgram year20222 payments
- Gilead Sciences, Inc.Program year20213 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
46.2%Macrolide Antimicrobial30.8%Azithromycin100%Part D≥25 patientsTetracycline-class Drug15.4%Minocycline Hcl100%Part D<11 patientsAntiparasitic
35.2%Antimalarial35.2%Atovaquone-Proguanil Hcl100%Part D≥30 patientsSensory organs
18.7%Fluoroquinolone Antibacterial18.7%Ciprofloxacin Hcl100%Part D≥17 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Integrated Genomic and Social Network Analyses of SARS-CoV-2 Transmission in the Healthcare Setting
Clinical Infectious Diseases
2024 - The Long Haul to Surgery: Long COVID Has Minimal Burden on Surgical Departments
International Journal of Environmental Research and Public Health
2024 - Longitudinal evaluation of <scp>neurologic‐post</scp> acute sequelae <scp>SARS‐CoV</scp>‐2 infection symptoms
Annals of Clinical and Translational Neurology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Ariel Feldstein, MD
Pfizer
Johanna Bendell, MD
Pfizer
Alejandra Gurtman, MD
Pfizer
Ruth Bailey
Pfizer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”